Epoch Biodesign
EMEA
London
,
United Kingdom
Startup
FOUNDED
2019
HEADCOUNT
21-100
FUNDING
Series A
Keywords:
enzymes, AI/ML, synthetic_biology, plastics_recycling
BUSINESS
Epoch Biodesign (formerly Mellizyme) is a London-based enzymatic plastic recycling company founded in 2019, with approximately 45–50 employees. Key commercial partnerships include INVISTA (inventor of nylon 6,6), Lululemon, and over 30 apparel/textile brands
BIOTECH INVOLVEMENT
Core: AI + synthetic biology for enzyme design and biorecycling of hard-to-recycle materials. Epoch uses AI-driven computational enzyme design and synthetic biology to engineer novel enzymes capable of deconstructing nylon 6,6 and other plastics at low temperatures into high-purity monomers for circular reuse. The platform combines physics-based modeling, generative AI, and proprietary biological datasets to create enzymes with functionalities not found in nature; downstream chemical engineering converts depolymerized output into virgin-quality recycled feedstocks.
TECHNOLOGY PLATFORM
AI enzyme engineering; enzymatic depolymerization
PRIMARY PRODUCTS
Recycled nylon 6,6 and other polymers